Redox proteomic identification of oxidized cardiac proteins in Adriamycin-treated mice

Free Radical Biology and Medicine

Volumn 41, Issue 9, 2006, Pages 1470-1477

  Chen, Yumin ^a   Daosukho, Chotiros ^a,b   Opii, Wycliffe O ^a   Turner, Delano M ^c   Pierce, William M ^c   Klein, Jon B ^d   Vore, Mary ^a   Butterfield, D Allan ^a   St Clair, Daret K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Enolase; Adriamycin; Electron transfer flavoprotein ubiquinone oxidoreductase; Free radicals; Oxidative stress; Redox proteomics; Triose phosphate isomerase

Indexed keywords

BETA ENOLASE; CARBONYL DERIVATIVE; CARDIAC PROTEIN; DOXORUBICIN; ELECTRON TRANSFERRING FLAVOPROTEIN; ENOLASE; FREE RADICAL; PROTEIN DERIVATIVE; TRIOSEPHOSPHATE ISOMERASE; UBIQUINONE DERIVATIVE; UBIQUINONE OXIDOREDUCTASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; BODY WEIGHT; CONTROLLED STUDY; ELECTRON TRANSPORT; ENERGY YIELD; ENZYME ACTIVITY; ENZYME PURIFICATION; FENTON REACTION; GLYCOLYSIS; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; RAT; RESPIRATORY CHAIN;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; DOXORUBICIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEART; HYDROGEN PEROXIDE; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEINS; PROTEOMICS;

MURINAE;

EID: 33749049359     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.08.006     Document Type: Article

References (62)

1. Buzdar A.U., Marcus C., Smith T.L., and Blumenschein G.R. Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 55 (1985) 2761-2765
2. Singal P.K., Deally C.M., and Weinberg L.E. Subcellular effects of adriamycin in the heart: a concise review. J. Mol. Cell. Cardiol. 19 (1987) 817-828
3. Lebrecht D., Kokkori A., Ketelsen U.P., Setzer B., and Walker U.A. Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin. J. Pathol. 207 (2005) 436-444
4. Kusuoka H., Futaki S., Koretsune Y., Kitabatake A., Suga H., Kamada T., and Inoue M. Alterations of intracellular calcium homeostasis and myocardial energetics in acute adriamycin-induced heart-failure. J. Cardiovasc. Pharmacol. 18 (1991) 437-444
5. Solem L.E., Henry T.R., and Wallace K.B. Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol. Appl. Pharmacol. 129 (1994) 214-222
6. Kotamraju S., Chitambar C.R., Kalivendi S.V., Joseph J., and Kalyanaraman B. Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells-Role of oxidant-induced iron signaling in apoptosis. J. Biol. Chem. 277 (2002) 17179-17187
7. Minotti G., Cairo G., and Monti E. Role of iron in anthracycline cardiotoxicity: new tunes for an old song?. FASEB J. 13 (1999) 199-212
8. Doroshow J.H. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 43 (1983) 460-472
9. Kotamraju S., Kalivendi S.V., Konorev E., Chitambar C.R., Joseph J., and Kalyanaraman B. Oxidant-induced iron signaling in doxorubicin-mediated apoptosis. Methods Enzymol. 378 (2004) 362-382
10. Vasquezvivar J., Martasek P., Hogg N., Masters B.S.S., Pritchard K.A., and Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 36 (1997) 11293-11297
11. Vasquez-Vivar J., Kalyanaraman B., and Kennedy M.C. Mitochondrial aconitase is a source of hydroxyl radical-An electron spin resonance investigation. J. Biol. Chem. 275 (2000) 14064-14069
12. Doroshow J.H. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase. Cancer Res. 43 (1983) 4543-4551
13. Myers C.E., Mcguire W.P., Liss R.H., Ifrim I., Grotzinger K., and Young R.C. Adriamycin-Role of lipid peroxidation in cardiac toxicity and tumor response. Science 197 (1977) 165-167
14. Joshi G., Sultana R., Tangpong J., Cole M.P., St Clair D.K., Vore M., Estus S., and Butterfield D.A. Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain. Free Radic. Res. 39 (2005) 1147-1154
15. Merten K.E., Feng W., Zhang L., Pierce W., Cai J., Klein J.B., and Kang Y.J. Modulation of cytochrome c oxidase-Va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity. J. Pharmacol. Exp. Ther. 315 (2005) 1314-1319
16. Jungblut P., Otto A., Zeindleberhart E., Pleissner K.P., Knecht M., Regitzzagrosek V., Fleck E., and Wittmannliebold B. Protein-composition of the human heart-The construction of a myocardial 2-dimensional electrophoresis database. Electrophoresis 15 (1994) 685-707
17. Redox proteomics: from protein modifications to cellular dysfunction and diseases. In: Dalle-Donne I., Scaloni A., and Butterfield D.A. (Eds) (2006), Wiley, New York
18. Butterfield D.A., and Boyd-Kimball D. Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration. Int. Rev. Neurobiol. 61 (2004) 161-188
19. Butterfield D.A. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res. 1000 (2004) 1-7
20. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
21. Levine R.L., Williams J.A., Stadtman E.R., and Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233 (1994) 346-357
22. Boyd-Kimball D., Castegna A., Sultana R., Poon H.F., Petroze R., Lynn B.C., Klein J.B., and Butterfield D.A. Proteomic identification of proteins oxidized by Aβ(1-42) in synaptosomes: implications for Alzheimer's disease. Brain Res. 1044 (2005) 206-215
23. Thongboonkerd V., Luengpailin J., Cao J., Pierce W.M., Cai J., Klein J.B., and Doyle R.J. Fluoride exposure attenuates expression of Streptococcus pyrogenes virulence factors. J. Biol. Chem. 277 (2002) 16599-16605
24. Perluigi M., Poon F.H., Hensley K., Pierce W.M., Klein J.B., Calabrese V., De Marco C., and Butterfield D.A. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-A model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 38 (2005) 960-968
25. Esnouf M.P., Harris R.P., and Mcvittie J.D. Triosephosphate isomerase from chicken and rabbit muscle. Methods Enzymol. 89 (1982) 579-583
26. Maurer M.H., Feldmann R.E., Bromme J.O., and Kalenka A. Comparison of statistical approaches for the analysis of proteome expression data of differentiating neural stem cells. J. Proteome Res. 4 (2005) 96-100
27. Levine R.L. Oxidative modification of glutamine-synthetase: II. Characterization of the ascorbate model system. J. Biol. Chem. 258 (1983) 1828-1833
28. Stadtman E.R. Protein oxidation and aging. Science 257 (1992) 1220-1224
29. Lehman T.C., Hale D.E., Bhala A., and Thorpe C. An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. Anal. Biochem. 186 (1990) 280-284
30. Kanski J., Aksenova M., Stoyanova A., and Butterfield D.A. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J. Nutr. Biochem. 13 (2002) 273-281
31. Bashore T.M., Magorien D.J., Letterio J., Shaffer P., and Unverferth D.V. Histologic and biochemical correlates of left-ventricular chamber dynamics in man. J. Am. Coll. Cardiol. 9 (1987) 734-742
32. Kaye D.M., Jennings G., and Angus J.A. Evidence for impaired endothelium-dependent vasodilation in experimental left-ventricular dysfunction. Clin. Exp. Pharmacol. Physiol. 21 (1994) 709-719
33. Paulsen K.E., Orville A.M., Frerman F.E., Lipscomb J.D., and Stankovich M.T. Redox properties of electron-transfer flavoprotein ubiquinone oxidoreductase as determined by EPR-spectroelectrochemistry. Biochemistry 31 (1992) 11755-11761
34. Knowles J.R. Enzyme catalysis-Not different, just better. Nature 350 (1991) 121-124
35. Meier-Ruge W., Iwangoff P., and Reichlmeier K. Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch. Gerontol. Geriatr. 3 (1984) 161-165
36. Poon H.F., Castegna A., Farr S.A., Thongboonkerd V., Lynn B.C., Banks W.A., Morley J.E., Klein J.B., and Butterfield D.A. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 126 (2004) 915-926
37. 8-barrel enzyme fold. Chem. Rev. 105 (2005) 4038-4055
38. Dhar-Chowdhury P., Harrell M.D., Han S.Y., Jankowska D., Parachuru L., Morrissey A., Srivastava S., Liu W.X., Malester B., Yoshida H., and Coetzee W.A. The glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase, triose-phosphate isomerase, and pyruvate kinase are components of the KATP channel macromolecular complex and regulate its function. J. Biol. Chem. 280 (2005) 38464-38470
39. Yu J.S., and Noll K.M. Phosphoglycerate kinase-triose-phosphate isomerase complex from Thermotoga neapolitana. Methods Enzymol. 331 (2001) 78-89
40. Orosz F., and Ovadi J. Dynamic interactions of enzymes involved in triosephosphate metabolism. Eur. J. Biochem. 160 (1986) 615-619
41. Krietsch W.K., Pentchev P.G., Klingenb H., Hofstatt T., and Bucher T. Isolation and crystallization of yeast and rabbit liver triose phosphate isomerase and a comparative characterization with rabbit muscle enzyme. Eur. J. Biochem. 14 (1970) 289-300
42. Merkulova T., Dehaupas M., Nevers M.C., Creminon C., Alameddine H., and Keller A. Differential modulation of α, β and γ enolase isoforms in regenerating mouse skeletal muscle. Eur. J. Biochem. 267 (2000) 3735-3743
43. Cabiscol E., Piulats E., Echave P., Herrero E., and Ros J. Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae. J. Biol. Chem. 275 (2000) 27393-27398
44. Tamarit J., Cabiscol E., and Ros J. Identification of the major oxidatively damaged proteins in Escherichia coli cells exposed to oxidative stress. J. Biol. Chem. 273 (1998) 3027-3032
45. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Markesbery W.R., and Butterfield D.A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain; Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J. Neurochem. 82 (2002) 1524-1532
46. Barreiro E., Gea J., Di Falco M., Kriazhev L., James S., and Hussain S.N.A. Protein carbonyl formation in the diaphragm. Am. J. Respir. Cell. Mol. Biol. 32 (2005) 9-17
47. Fletcher L., Rider C.C., Taylor C.B., Adamson E.D., Luke B.M., and Graham C.F. Enolase isoenzymes as markers of differentiation in teratocarcinoma cells and normal tissues of mouse. Dev. Biol. 65 (1978) 462-475
48. Keller A., Rouzeau J.D., Farhadian F., Wisnewsky C., Marotte F., Lamande N., Samuel J.L., Schwartz K., Lazar M., and Lucas M. Differential expression of α- and β-enolase genes during rat heart development and hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 38 (1995) 1843-1851
49. Singal P.K. Ultrastructural evidence for increased sensitivity of the hypertrophied heart to adriamycin. Perspect. Cardiovasc. Res. 7 (1983) 197-209
50. Simkovic M., and Frerman F.E. Alternative quinone substrates and inhibitors of human electron-transfer flavoprotein-ubiquinone oxidoreductase. Biochem. J. 378 (2004) 633-640
51. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64 (1995) 97-112
52. Rosenoff S.H., Olson H.M., Young D.M., Bostick F., and Young R.C. Adriamycin-induced cardiac damage in mouse-Small-animal model of cardiotoxicity. J. Natl. Cancer Inst. 55 (1975) 191-194
53. Yen H.C., Oberley T.D., Vichitbandha S., Ho Y.S., and Stclair D.K. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest. 98 (1996) 1253-1260
54. Chaiswing L., Cole M.P., St Clair D.K., Ittarat W., Szweda L.I., and Oberley T.D. Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury. Toxicol. Pathol. 32 (2004) 536-547
55. Lien Y.C., Lin S.M., Nithipongvanitch R., Oberley T.D., Noel T., Zhao Q., Daosukho C., and St Clair D.K. Tumor necrosis factor receptor deficiency exacerbated adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection. Mol. Cancer Ther. 5 (2006) 261-269
56. Yi X.M., Bekeredjian R., Defilippis N.J., Siddiquee Z., Fernandez E., and Shohet R.V. Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) 1098-1102
57. Lebrecht D., Setzer B., Ketelsen U.P., Haberstroh J., and Walker U.A. Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation 108 (2003) 2423-2429
58. Chabner B.A., Ryan D.P., Paz-Ares L., Garcia-Carbonero R., and Calabresi P. Antineoplastic agents. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics (2001), McGraw-Hill, New York 1389-1459
59. Piscitelli S.C., Rodvold K.A., Rushing D.A., and Tewksbury D.A. Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small-cell lung-cancer. Clin. Pharmacol. Ther. 53 (1993) 555-561
60. Yen H.C., Oberley T.D., Gairola C.G., Szweda L.I., and St. Clair D.K. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch. Biochem. Biophys. 362 (1999) 59-66
61. Chaiswing L., Cole M.P., Ittarat W., Szweda L.I., St Clair D.K., and Oberley T.D. Manganese superoxide dismutase and inducible nitric oxide synthase modify early oxidative events in acute adriamycin-induced mitochondrial toxicity. Mol. Cancer Ther. 4 (2005) 1056-1064
62. Kang Y.J., Sun X.H., Chen Y., and Zhou Z.X. Inhibition of doxorubicin chronic toxicity in catalase-overexpressing transgenic mouse hearts. Chem. Res. Toxicol. 15 (2002) 1-6